Effects of N-[N-(3, 5-difluorophenacetyl-l-alanyl)]-S-phenylglycine t-butyl ester (DAPT) on cell proliferation and apoptosis in Ishikawa endometrial cancer cells

Human Cell

Volumn 25, Issue 1, 2012, Pages 9-15

  Mori, Michihiro ^a   Miyamoto, Tomoyuki ^a,b   Yakushiji, Hiromasa ^a   Ohno, Setsuyo ^a,b   Miyake, Yasuyuki ^a,b   Sakaguchi, Takuya ^a,b   Hattori, Manabu ^c   Hongo, Atsushi ^d   Nakaizumi, Akihiko ^e   Ueda, Masatsugu ^f   Ohno, Eiji ^a,b  

^a KURASHIKI UNIVERSITY OF SCIENCE AND THE ARTS   (Japan)

^b Kake Institute of Cytopathology   (Japan)

^c KITASATO UNIVERSITY   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f Osaka Cancer Prevention and Detection Center   (Japan)

Author keywords

Apoptosis; Cell proliferation; Endometrial neoplasms; N N (3, 5 difluorophenacetyl l alanyl) S phenylglycine t butyl ester; Notch1

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN A; GAMMA SECRETASE INHIBITOR; MESSENGER RNA; N [N (3,5 DIFLUOROPHENACETYL LEVO ALANYL)] S PHENYLGLYCINE TERT BUTYL ESTER; NOTCH RECEPTOR; NOTCH1 RECEPTOR; PROTEIN P21; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; ENDOMETRIUM CANCER; GENE EXPRESSION; GENE TARGETING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

AMYLOID PRECURSOR PROTEIN SECRETASES; APOPTOSIS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE, TUMOR; CELL PROLIFERATION; DIPEPTIDES; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; RECEPTOR, NOTCH1; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84858223606     PISSN: 09147470     EISSN: 17490774     Source Type: Journal    
DOI: 10.1007/s13577-011-0038-8     Document Type: Article

References (24)

1. Okuda T, Sekizawa A, Purwosunu Y, et al. Genetics of endometrial cancers. Obstet Gynecol Int. 2010; 2010: 984013.
2. Masciullo V, Amadio G, Lo Russo D, Raimondo I, Giordano A, Scambia G. Controversies in the management of endometrial cancer. Obstet Gynecol Int. 2010; 2010: 638165.
3. Bakkum-Gamez JN, Gonzalez-Bosquet J, Laack NN, Mariani A, Dowdy SC. Current issues in the management of endometrial cancer. Mayo Clin Proc. 2008; 83: 97-112.
4. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science. 1999; 284: 770-6.
5. Wilson A, Radtke F. Multiple functions of Notch signaling in self-renewing organs and cancer. FEBS Lett. 2006; 580: 2860-8.
6. Grottkau BE, Chen XR, Friedrich CC, et al. DAPT enhances the apoptosis of human tongue carcinoma cells. Int J Oral Sci. 2009; 1: 81-9.
7. Allenspach EJ, Maillard I, Aster JC, Pear WS. Notch signaling in cancer. Cancer Biol Ther. 2002; 1: 466-76.
8. Bolós V, Grego-Bessa J, de la Pompa JL. Notch signaling in development and cancer. Endocr Rev. 2007; 28: 339-63.
9. Kunnimalaiyaan M, Chen H. Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors. Oncologist. 2007; 12: 535-42.
10. Ellisen LW, Bird J, West DC, et al. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell. 1991; 66: 649-61.
11. Reedijk M, Odorcic S, Chang L, et al. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res. 2005; 65: 8530-7.
12. Wang Z, Zhang Y, Li Y, Banerjee S, Liao J, Sarkar FH. Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Mol Cancer. 2006; 5: 483-93.
13. Chu D, Li Y, Wang W, et al. High level of Notch1 protein is associated with poor overall survival in colorectal cancer. Ann Surg Oncol. 2010; 17: 1337-42.
14. Leethanakul C, Patel V, Gillespie J, et al. Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene. 2000; 19: 3220-4.
15. Kunnimalaiyaan M, Vaccaro AM, Ndiaye MA, Chen H. Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells. J Biol Chem. 2006; 281: 39819-30.
16. Sriuranpong V, Borges MW, Ravi RK, et al. Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res. 2001; 61: 3200-5.
17. Suzuki T, Aoki D, Susumu N, Udagawa Y, Nozawa S. Imbalanced expression of TAN-1 and human Notch4 in endometrial cancers. Int J Oncol. 2000; 17: 1131-9.
18. Cobellis L, Caprio F, Trabucco E, et al. The pattern of expression of Notch protein members in normal and pathological endometrium. J Anat. 2008; 213: 464-72.
19. Wang M, Wu L, Wang L, Xin X. Down-regulation of Notch1 by gamma-secretase inhibition contributes to cell growth inhibition and apoptosis in ovarian cancer cells A2780. Biochem Biophys Res Commun. 2010; 393: 144-9.
20. Weng AP, Ferrando AA, Lee W, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004; 306: 269-71.
21. Kabos P, Kabosova A, Neuman T. Blocking HES1 expression initiates GABAergic differentiation and induces the expression of p21 (CIP1/WAF1) in human neural stem cells. J Biol Chem. 2002; 277: 8763-6.
22. Jang MS, Miao H, Carlesso N, et al. Notch-1 regulates cell death independently of differentiation in murine erythroleukemia cells through multiple apoptosis and cell cycle pathways. J Cell Physiol. 2004; 199: 418-33.
23. Niculescu AB 3rd, Chen X, Smeets M, Hengst L, Prives C, Reed SI. Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol. 1998; 18: 629-43.
24. Tsao YP, Huang SJ, Chang JL, Hsieh JT, Pong RC, Chen SL. Adenovirus-mediated p21((WAF1/SDII/CIP1)) gene transfer induces apoptosis of human cervical cancer cell lines. J Virol. 1999; 73: 4983-90.